Event Brief
Mar 10, 2026 at 12:03 PM ET
Vertex passes key test in quest to treat kidney diseases
By The BriefBrief
Vertex Pharmaceuticals' drug for kidney condition succeeded in a Phase 3 trial, marking a significant step for the company.
WHO: Vertex Pharmaceuticals
WHAT: Drug for immunoglobulin A nephropathy succeeded in Phase 3 trial
WHEN: Mar 10, 2026 at 11:03 AM ET
WHERE: Boston
WHY: To diversify beyond cystic fibrosis treatments
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21400 of 21400
Same format. Every time.
Continue reading — sign in or create a free account with
